Medtronic PLC Net Income Over Time
| MDT Stock | USD 102.96 1.96 1.94% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Medtronic PLC Performance and Medtronic PLC Correlation. Medtronic | Build AI portfolio with Medtronic Stock |
Is there potential for Health Care Equipment & Supplies market expansion? Will Medtronic introduce new products? Factors like these will boost the valuation of Medtronic PLC. Expected growth trajectory for Medtronic significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.081 | Dividend Share 2.82 | Earnings Share 3.69 | Revenue Per Share | Quarterly Revenue Growth 0.066 |
Understanding Medtronic PLC requires distinguishing between market price and book value, where the latter reflects Medtronic's accounting equity. The concept of intrinsic value—what Medtronic PLC's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Medtronic PLC's price substantially above or below its fundamental value.
Understanding that Medtronic PLC's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Medtronic PLC represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Medtronic PLC's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Net Income Analysis
Compare Medtronic PLC and related stocks such as Stryker, HCA Holdings, and Boston Scientific Corp Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SYK | 8.4 M | 1.3 B | 1.3 B | 1 B | 515 M | 1.4 B | 1.6 B | 1 B | 3.6 B | 2.1 B | 1.6 B | 2 B | 2.4 B | 3.2 B | 3 B | 3.4 B | 3.6 B |
| BSX | 41.8 M | 441 M | (4.1 B) | (121 M) | (119 M) | (239 M) | 347 M | 104 M | 1.7 B | 4.7 B | (82 M) | 1 B | 698 M | 1.6 B | 1.9 B | 2.1 B | 2.2 B |
| MCK | 404.5 M | 1.4 B | 1.3 B | 1.3 B | 1.5 B | 2.3 B | 5.2 B | 67 M | 34 M | 900 M | (4.5 B) | 1.1 B | 3.6 B | 3 B | 3.3 B | 3.8 B | 4 B |
| VRTX | (4.3 M) | 29.6 M | (107 M) | (445 M) | (738.6 M) | (558.1 M) | (112.1 M) | 263.5 M | 2.1 B | 1.2 B | 2.7 B | 2.3 B | 3.3 B | 3.6 B | (535.6 M) | (615.9 M) | (585.1 M) |
| SNY | 625 M | 5.6 B | 4.9 B | 3.7 B | 4.4 B | 4.3 B | 4.7 B | 8.4 B | 4.3 B | 2.8 B | 12.3 B | 6.2 B | 8.4 B | 5.4 B | 5.6 B | 6.4 B | 4.9 B |
| EW | 82 M | 236.7 M | 293.2 M | 391.7 M | 811.1 M | 494.9 M | 569.5 M | 622.1 M | 722.2 M | 1 B | 823.4 M | 1.5 B | 1.5 B | 1.4 B | 4.2 B | 4.8 B | 5 B |
| BMY | 1.1 B | 3.7 B | 2 B | 2.6 B | 2 B | 1.6 B | 4.5 B | 1 B | 4.9 B | 3.4 B | (9 B) | 7 B | 6.3 B | 8 B | (8.9 B) | (8.1 B) | (7.7 B) |
| GSK | 400 M | 5.3 B | 4.5 B | 5.4 B | 2.8 B | 8.4 B | 912 M | 1.5 B | 3.6 B | 4.6 B | 5.7 B | 4.4 B | 15 B | 4.9 B | 2.6 B | 3 B | 3.7 B |
| CVS | 210.2 M | 3.5 B | 3.9 B | 4.6 B | 4.6 B | 5.2 B | 5.3 B | 6.6 B | (594 M) | 6.6 B | 7.2 B | 8 B | 4.3 B | 8.3 B | 4.6 B | 5.3 B | 5.6 B |
Medtronic PLC and related stocks such as Stryker, HCA Holdings, and Boston Scientific Corp Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Medtronic PLC financial statement analysis. It represents the amount of money remaining after all of Medtronic PLC operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Medtronic PLC | MDT |
| Classification | Dividend Beast |
| Business Address | Building Two, Galway, |
| Exchange | New York Stock Exchange |
USD 102.96
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.